Edition:
United States

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

94.13USD
10:22am EST
Change (% chg)

$-1.37 (-1.43%)
Prev Close
$95.50
Open
$94.40
Day's High
$94.75
Day's Low
$93.78
Volume
232,067
Avg. Vol
1,445,880
52-wk High
$100.15
52-wk Low
$76.42

Latest Key Developments (Source: Significant Developments)

Medtronic Plc says on Dec 12, co's unit entered into amended and restated credit agreement - SEC Filing
Thursday, 13 Dec 2018 05:14pm EST 

Dec 13 (Reuters) - Medtronic PLC ::MEDTRONIC PLC SAYS ON DECEMBER 12, CO'S UNIT ENTERED INTO AMENDED AND RESTATED CREDIT AGREEMENT - SEC FILING.MEDTRONIC PLC SAYS CREDIT AGREEMENT PROVIDES FOR $3.5 BILLION FIVE-YEAR UNSECURED REVOLVING CREDIT FACILITY.  Full Article

Medtronic Receives Health Canada License For Visualase MRI-Guided Laser Ablation System
Thursday, 22 Nov 2018 01:32pm EST 

Nov 22 (Reuters) - Medtronic PLC ::MEDTRONIC RECEIVES HEALTH CANADA LICENCE FOR VISUALASE MRI-GUIDED LASER ABLATION SYSTEM.MEDTRONIC OF CANADA SAYS RECEIVED A LICENCE FROM HEALTH CANADA FOR VISUALASE MRI-GUIDED LASER ABLATION SYSTEM.  Full Article

Medtronic Q2 Non-GAAP Earnings Per Share $1.22
Tuesday, 20 Nov 2018 06:45am EST 

Medtronic PLC ::REG-MEDTRONIC REPORTS SECOND QUARTER FINANCIAL RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $1.22.Q2 GAAP EARNINGS PER SHARE $0.82.Q2 EARNINGS PER SHARE VIEW $1.15 -- THOMSON REUTERS I/B/E/S.SEES FY 2019 NON-GAAP EARNINGS PER SHARE $5.10 TO $5.15 INCLUDING ITEMS.QTRLY REVENUE OF $7.5 BILLION INCREASED 6.1% REPORTED; INCREASED 7.5% ORGANIC.CVG WORLDWIDE Q2 REVENUE OF $2.858 BILLION INCREASED 3.1 PERCENT, OR 4.4 PERCENT ON A CONSTANT CURRENCY BASIS.UPDATED ITS FISCAL YEAR 2019 GUIDANCE.FOR FISCAL YEAR 2019, INCREASING ITS ORGANIC REVENUE GROWTH GUIDANCE TO A RANGE OF 5.0 TO 5.5 PERCENT.MEDTRONIC - IF RECENT EXCHANGE RATES HOLD FOR REMAINDER OF FISCAL YEAR, FY 2019 REVENUE WOULD BE NEGATIVELY AFFECTED BY ABOUT $420 MILLION TO $520 MILLION.MEDTRONIC - OPERATIONAL OUTPERFORMANCE IN H1 2019 IS ALLOWING CO TO ABSORB INCREMENTAL EXPENSES INCLUDING EXPECTED IMPACTS OF CHINA TARIFFS.MEDTRONIC - IF RECENT EXCHANGE RATES HOLD FOR REMAINDER OF FY, FOREIGN EXCHANGE WOULD HAVE NEUTRAL IMPACT ON FY 2019 EPS.  Full Article

Mazor Robotics Shareholders Approve Merger Agreement With Medtronic
Monday, 19 Nov 2018 05:31pm EST 

Nov 19 (Reuters) - Mazor Robotics Ltd ::MAZOR ROBOTICS SHAREHOLDERS APPROVE MERGER AGREEMENT WITH MEDTRONIC.MAZOR ROBOTICS LTD - APPROXIMATELY 95 PERCENT OF SHARES REPRESENTED IN MEETING WERE CAST IN FAVOR OF MERGER.MAZOR ROBOTICS LTD - MERGER AGREEMENT WITH MEDTRONIC EXPECTED TO CLOSE DURING MEDTRONIC'S THIRD FISCAL QUARTER ENDING JANUARY 25, 2019.  Full Article

Medtronic Says FDA Approves SynchroMed(TM) II myPTM(TM) Personal Therapy Manager
Wednesday, 24 Oct 2018 10:00am EDT 

Oct 24 (Reuters) - Medtronic PLC ::FDA APPROVES NEW SYNCHROMED(TM) II MYPTM(TM) PERSONAL THERAPY MANAGER THAT ENABLES PATIENTS TO ALLEVIATE UNPREDICTABLE PAIN.  Full Article

Medtronic Gets FDA Approval For Valiant Navion Thoracic Stent Graft System
Tuesday, 23 Oct 2018 09:00am EDT 

Oct 23 (Reuters) - Medtronic PLC ::MEDTRONIC RECEIVES FDA APPROVAL FOR VALIANT NAVION(TM) THORACIC STENT GRAFT SYSTEM.MEDTRONIC - APPROVAL BASED ON 30-DAY PRIMARY ENDPOINT ANALYSIS 87 SUBJECTS CONSECUTIVELY ENROLLED IN INTERNATIONAL, MULTICENTER, PROSPECTIVE IDE STUDY.  Full Article

Medtronic Co-Founder Earl Bakken Passes Away At Age 94
Sunday, 21 Oct 2018 10:57pm EDT 

Oct 21 (Reuters) - Medtronic PLC ::MEDTRONIC CO-FOUNDER EARL BAKKEN PASSES AWAY AT AGE 94.CO-FOUNDER, EARL E. BAKKEN, PASSED AWAY ON OCT 21, 2018.  Full Article

Mazor Robotics To Pay Medtronic Plc $60.8 Mln If Deal Is Terminated
Monday, 24 Sep 2018 06:35pm EDT 

Sept 24 (Reuters) - Medtronic PLC ::MAZOR ROBOTICS SAYS CO TO PAY MEDTRONIC PLC $60.8 MILLION IF DEAL IS TERMINATED UNDER CERTAIN CIRCUMSTANCES- SEC FILING.  Full Article

Medtronic To Acquire Mazor Robotics for $1.64 bln
Thursday, 20 Sep 2018 06:57pm EDT 

Sept 20 (Reuters) - Medtronic Plc ::MEDTRONIC TO ACQUIRE MAZOR ROBOTICS.MEDTRONIC - ENTERED INTO A DEFINITIVE MERGER AGREEMENT UNDER WHICH MEDTRONIC WILL ACQUIRE ALL OUTSTANDING ORDINARY SHARES OF MAZOR FOR $58.50 PER ADS.SAYS BOARDS OF DIRECTORS OF BOTH COMPANIES HAVE UNANIMOUSLY APPROVED TRANSACTION.TRANSACTION IS EXPECTED TO BE MODESTLY DILUTIVE TO CO'S FISCAL 2019 ADJUSTED EARNINGS PER SHARE.MEDTRONIC - CO PROJECTS ACQUISITION TO GENERATE A DOUBLE-DIGIT RETURN ON INVESTED CAPITAL BY YEAR FOUR, WITH AN INCREASING CONTRIBUTION THEREAFTER.MEDTRONIC-ENTERED AGREEMENT TO ACQUIRE MAZOR ROBOTICS FOR TOTAL OF ABOUT $1.64 BILLION, OR $1.34 BILLION NET OF CO'S EXISTING STAKE IN MAZOR AND CASH ACQUIRED.  Full Article

Medtronic Receives FDA Approval For Implantable System For Remodulin To Treat Patients With Pulmonary Arterial Hypertension
Tuesday, 31 Jul 2018 06:15am EDT 

July 31 (Reuters) - Medtronic PLC ::MEDTRONIC RECEIVES FDA APPROVAL FOR IMPLANTABLE SYSTEM FOR REMODULIN® TO TREAT PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION.MEDTRONIC PLC - MEDTRONIC SYNCHROMED(TM) II PUMP, PROPRIETARY CATHETER DELIVER UNITED THERAPEUTICS' REMODULIN® (TREPROSTINIL) INJECTION.  Full Article

Photo

Israel grants $33 million to GE, Medtronic, Change Healthcare to boost R&D

JERUSALEM Three multinational companies have received an Israeli government grant of 120 million shekels ($33 million) aimed at boosting the presence of large companies and establishing Israel as a hub in biotechnology and medicine.